IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biomark Capital Management Co. LLC

Q4 2015 Holdings

Filed 2016-02-16 | 3 holdings | $11.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics, Inc.(ADMA)COMMON STOCK000899104$11.6M1,433,30499.4%
Juno Therapeutics, Inc.COMMON STOCK48205A109$70.5K1,602,5620.6%
Mabvax Therapeutics Holdings, Inc.COMMON STOCK55414P108$136197,6410.0%